# Encore PFO Closure Device - The PerFOrm Trial

> **NCT05537753** · NA · RECRUITING · sponsor: **Encore Medical Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Patent Foramen Ovale
- Cryptogenic Stroke

## Interventions

- **DEVICE:** Encore PFO closure device
- **DEVICE:** FDA-approved PFO closure device

## Key facts

- **NCT ID:** NCT05537753
- **Lead sponsor:** Encore Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-12
- **Primary completion:** 2026-04
- **Final completion:** 2030-10
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05537753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05537753, "Encore PFO Closure Device - The PerFOrm Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05537753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*